Current Worldwide Trends in Pediatric Helicobacter pylori Antimicrobial Resistance

被引:12
|
作者
Balas, Reka Borka [1 ]
Melit, Lorena Elena [1 ]
Marginean, Cristina Oana [1 ]
机构
[1] George Emil Palade Univ Med Pharm Sci & Technol, Dept Pediat 1, Gheorghe Marinescu St 38, Targu Mures 540136, Romania
来源
CHILDREN-BASEL | 2023年 / 10卷 / 02期
关键词
Helicobacter pylori; antimicrobial resistance; children; STANDARD TRIPLE THERAPY; SECONDARY ANTIBIOTIC-RESISTANCE; CLARITHROMYCIN RESISTANCE; HIGH PREVALENCE; LEVOFLOXACIN RESISTANCE; ISRAELI CHILDREN; BABA2; GENOTYPES; INFECTION; ADOLESCENTS; ERADICATION;
D O I
10.3390/children10020403
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Helicobacter pylori (H. pylori) has acquired several resistance mechanisms in order to escape the currently used eradication regimens such as mutations that impair the replication, recombination, and transcription of DNA; the antibiotics capability to interact with protein synthesis and ribosomal activity; the adequate redox state of bacterial cells; or the penicillin-binding proteins. The aim of this review was to identify the differences in pediatric H. pylori antimicrobial-resistance trends between continents and countries of the same continent. In Asian pediatric patients, the greatest antimicrobial resistance was found to metronidazole (>50%), probably due to its wide use for parasitic infections. Aside from the increased resistance to metronidazole, the reports from different Asian countries indicated also high resistance rates to clarithromycin, suggesting that ciprofloxacin-based eradication therapy and bismuth-based quadruple therapy might be optimal choices for the eradication of H. pylori in Asian pediatric population. The scarce evidence for America revealed that H. pylori strains display an increased resistance to clarithromycin (up to 79.6%), but not all studies agreed on this statement. Pediatric patients from Africa also presented the greatest resistance rate to metronidazole (91%), but the results in terms of amoxicillin remain contradictory. Nevertheless, the lowest resistance rates in most of the African studies were found for quinolones. Among European children, the most frequent antimicrobial resistance was also noticed for metronidazole and clarithromycin (up to 59% and 45%) but with a predominance for clarithromycin as compared to other continents. The differences in antibiotic use among continents and countries worldwide is clearly responsible for the discrepancies regarding H. pylori antimicrobial-resistance patterns, emphasizing the crucial role of global judicious antibiotic use in order to control the increasing resistance rates worldwide.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Helicobacter pylori antimicrobial resistance in a pediatric population
    Silva, Gisela M.
    Silva, Helena Moreira
    Nascimento, Joao
    Goncalves, Jean-Pierre
    Pereira, Fernando
    Lima, Rosa
    HELICOBACTER, 2018, 23 (05)
  • [2] Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam
    Trung Nam Phan
    Van Huy Tran
    Thi Nhu Hoa Tran
    Van An Le
    Santona, Antonella
    Rubino, Salvatore
    Paglietti, Bianca
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (06): : 609 - 613
  • [3] Helicobacter pylori resistance to current therapies
    Smith, Sinead M.
    O'Morain, Colm
    McNamara, Deirdre
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (01) : 6 - 13
  • [4] Factors associated with Helicobacter pylori antimicrobial resistance in a US pediatric cohort
    Riaz, Muhammad
    Chan, Christina
    Andrews, Christine
    Herzlinger, Michael
    Liu, Enju
    Bonilla, Silvana
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2025, 80 (01) : 87 - 99
  • [5] Multidrug resistance in Helicobacter pylori: current state and future directions
    Boyanova, Lyudmila
    Hadzhiyski, Petyo
    Kandilarov, Nayden
    Markovska, Rumyana
    Mitov, Ivan
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (09) : 909 - 915
  • [6] Recent trends in primary antimicrobial resistance of Helicobacter pylori in Finland
    Kostamo, Pirkko
    Veijola, Lea
    Oksanen, Aino
    Sarna, Seppo
    Rautelin, Hilpi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (01) : 22 - 25
  • [7] Prevalence of antimicrobial resistance in Helicobacter pylori isolates from Iran
    Sirous, M.
    Mehrabadi, Jalil F.
    Daryani, N. E.
    Eshraghi, S.
    Hajikhani, S.
    Shirazi, M. H.
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (36): : 5962 - 5965
  • [8] High Level of Antimicrobial Resistance in French Helicobacter pylori Isolates
    Raymond, Josette
    Lamarque, Dominique
    Kalach, Nicolas
    Chaussade, Stanislas
    Burucoa, Christophe
    HELICOBACTER, 2010, 15 (01) : 21 - 27
  • [9] Detection of Helicobacter pylori and Antimicrobial Resistance in Gastric Biopsy Specimens
    Cagdas, Umut
    Otag, Feza
    Tezcan, Seda
    Sezgin, Orhan
    Aslan, Gonul
    Emekdas, Gurol
    MIKROBIYOLOJI BULTENI, 2012, 46 (03): : 398 - 409
  • [10] PRIMARY ANTIMICROBIAL RESISTANCE OF HELICOBACTER PYLORI IN BELGIUM
    Vekens, K.
    Vandebosch, S.
    De, Bel A.
    Urbain, D.
    Mana, F.
    ACTA CLINICA BELGICA, 2013, 68 (03): : 183 - 187